Fuori onda

Storia in evoluzione · 1 servizio

The ChAdOx1 BDBV Phase I vaccine trial

Prima messa in onda Ultima messa in onda

In corsoProssima verifica il : Further enrollment and dosing, safety monitoring, and reported study results.

A che punto è

The Phase I safety study began with the first volunteer receiving a dose of ChAdOx1 BDBV in England on July 24, 2026. The study plans to enroll 50 healthy adults; enrollment, safety monitoring and results remain open, and the report gives no date for a next step.

CronistoriaGiorno 1

1 servizio9 testate11 fonti1 video

  • Ancora nessun evento datato
    1. Aggiornamento 1First Bundibugyo Ebola Vaccine Enters Human Arm as Outbreak Toll Tops 1,000

    La storia finora

    1. Aggiornamento 1

      First Bundibugyo Ebola Vaccine Enters Human Arm as Outbreak Toll Tops 1,000

      Oxford gave the first Bundibugyo Ebola vaccine dose on 24 July as Central Africa's death toll passed 1,000 — with the exact count still disputed.

      Ancora aperto dopo questo servizio

      • No verified final case and death counts, volunteer identity, or verbatim leadership quotes in provided sources.
      • No confirmed WHO emergency declaration wording or results date in provided sources.

    Cronologia

    1. Aperta1 servizio

    Chi è coinvolto

    Persone

    • Richard HatchettAmerican epidemiologist1 servizio

    Luoghi

    • Democratic Republic of the CongoDemocratic Republic of the Congo1 servizio
    • OxfordOxford, UK1 servizio
    • UgandaUganda1 servizio

    Tutte le testate che abbiamo letto su questa storia

    11 fonti9 testate1 video1 lancio d’agenzia

    Trattato anche in

    1. 16,000 Ebola Doses Land in Congo — For the Wrong Strain